Skip to main content

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics was previously published as Anti-Cancer Drug Design.

Publisher: Cognizant Communication Corporation

Volume 15, Number 6, 2005

Research article


Effect of Glibenclamide on N-Nitroso-N-Methylurea-Induced Mammary Tumors in Diabetic and Nondiabetic Rats
pp. 301-311(11)
Authors: Cocca, Claudia; Martín, Gabriela; Núñez, Mariel; Gutiérrez, Alicia; Cricco, Graciela; Mohamad, Nora; Medina, Vanina; Croci, Máximo; Crescenti, Ernesto; Rivera, Elena; Bergoc, Rosa


The Antineoplastic Efficacy of the Prodrug CloretazineTM Is Produced by the Synergistic Interaction of Carbamoylating and Alkylating Products of its Activation
pp. 313-325(13)
Authors: Baumann, Raymond P.; Seow, Helen A.; Shyam, Krishnamurthy; Penketh, Philip G.; Sartorelli, Alan C.


Inhibition of Protein Kinase CKII Activity by Euchrestaflavanone B Purified From Cudrania tricuspidata
pp. 327-332(6)
Authors: Kim, Soon-Hee; Yoon, Soo-Hyun; Lee, Byong Won; Park, Ki Hun; Kim, Young Ho; Bae, and Young-Seuk


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more